Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5

Abstract excerpt

As the immune protection through antibodies elicited by the first booster dose wanes over time and new Omicron sublineages emerge with stronger immune evasion from humoral anti-Spike responses, the need for variant-adapted coronavirus disease 2019 (COVID-19) vaccine boosters is increasingly imminent. On June 28, vaccine advisory committee of the US Food and Drug Administration (FDA) voted in favor of updating...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bacteriophages and microbial interactions
• Share to SARS-CoV-2 and COVID-19 Research
• Share to Viral gastroenteritis research and epidemiology